provider
Search result for "Solr search content"
Search Result for "bone cancer"
provider
Shraddha Dalwadi, MD, MBA Radiation Oncology, Breast Oncology
provider
Chul Ha, MD Radiation Oncology, Hematology-Oncology
provider
David Haile, MD Hematology, Stem Cell Transplantation, Internal Medicine
Clinical Trial
An International Prospective Open-label, Multi-center, Randomized, non-comparative Phase II Study of lutetium (177Lu) vipivotide tetraxetan (AAA617) alone and lutetium (177Lu) vipivotide tetraxetan (AAA617) in combination with Androgen Receptor Pathway In
The purpose of this study is to evaluate the efficacy and safety of AAA617 alone (Lutetium [177Lu] vipivotide tetraxetan) and in combination with an Androgen Receptor Pathway Inhibitors (ARPI) in participants with PSMA-positive, castration-resistant prostate cancer and no evidence of metastasis in conventional imaging (CI) (i.e., CT/MRI and bone scans). Approximately 120 participants will be randomized.
provider
Anand Karnad, M.D. Hematology/Oncology, Medical Oncology
provider
Debra Kent, DNP, MSN, APRN-PC, RN Pediatric Nurse Practitioner, Oncology Survivorship
provider